1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Dong JT, Suzuki H, Pin SS, et al. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res. 1996;56:4387–4390.
3. Shiwu WU, Lan Y, Wenqing S, et al. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer. Arch Iran Med. 2012;15:707–712.
4. Ma ZB, Li K, Wang J, Guo GH. Role of KAI1/CD82 polymorphisms in colon cancer risk in Han Chinese population. Med Oncol. 2013;30:668.
5. Zhang B, Liu W, Li L, et al. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma. Int J Clin Exp Pathol.. 2013;6:1060–1067.